“New Drug” Designations for New Therapeutic Entities: New Active Substance, New Chemical Entity, New Biological Entity, New Molecular Entity-Reference-Cited by-同舟云学术

“New Drug” Designations for New Therapeutic Entities: New Active Substance, New Chemical Entity, New Biological Entity, New Molecular Entity

Published:2014-09-04 Issue:21 Volume:57 Page:8729-8765
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Branch Sarah K.¹,Agranat Israel²

Affiliation:

1. Medicines and Healthcare products Regulatory Agency, 151 Buckingham Palace Road, London, SW1W 9SZ, U.K.

2. Organic Chemistry, Institute of Chemistry, The Hebrew University of Jerusalem, Philadelphia Building No. 201/205, Edmond J. Safra Campus, Jerusalem 91904, Israel

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm402001w

Reference176 articles.

1. Glossary of terms used in medicinal chemistry. Part II (IUPAC Recommendations 2013)

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reinventing Strategic Execution in the Pharmaceutical Industry;Strategic Management and International Business Policies for Maintaining Competitive Advantage;2023-06-09

2. The Quest for Secondary Pharmaceuticals: Drug Repurposing/Chiral-Switches Combination Strategy;ACS Pharmacology & Translational Science;2023-01-17

3. Enantioselective synthesis of axially chiral carbamates and amides with carbon dioxide via copper catalysis;Organic Chemistry Frontiers;2023

4. Chiral metallic anticancer drugs: A brief-review;European Journal of Chemistry;2022-12-31

5. NCX 470 Restores Ocular Hemodynamics and Retinal Cell Physiology After ET-1-Induced Ischemia/Reperfusion Injury of Optic Nerve and Retina in Rabbits;Journal of Ocular Pharmacology and Therapeutics;2022-09-01